wire - news in brief


Category



Results 101 - 150 of 367.


Pharmacology - Health - 01.11.2018
Phase III data showed that Venclexta/Venclyxto plus Gazyva/Gazyvaro reduced the risk of disease worsening or death in people with previously untreated chronic lymphocytic leukaemia with co-morbidities
The phase III CLL14 study compared Venclexta/Venclyxto in combination with Gazyva/Gazyvaro to standard-of-care Gazyva/Gazyvaro plus chlorambucil Data will be submitted to health authorities and prese

Pharmacology - Health - 01.11.2018
Roche to present new data from its industry-leading haematology portfolio at the American Society of Hematology 2018 Annual Meeting
Ten medicines featured in over 70 abstracts, including 25 oral presentations Additional data from three pivotal studies of Hemlibra in people with haemophilia A, with or without factor VIII inhibitor

Administration - 31.10.2018

Health - Life Sciences - 30.10.2018
Switzerland-wide platform for cell therapy launched in Bern
Regenerative Medicine is one of the fastest growing sectors in biomedical research - replacing diseased cells, tissues or organs.

Health - Innovation / Technology - 29.10.2018
Medical X-ray imaging made affordable
Medical X-ray imaging made affordable
The GlobalDiagnostiX X-ray system is about to go into production. This robust machine - initially designed for the challenging conditions of countries in the Global South - has also turned out to be an attractive solution for industrialized nations owing to its low cost.

Physics - Innovation / Technology - 29.10.2018
Successful ETH quantum researchers
In mid-2017, the European Commission launched a flagship project in the field of quantum technology.

Environment - Business / Economics - 29.10.2018
A New Alliance for Sustainability in Finance: California and Switzerland Team Up to Tackle a Key Factor in Implementing Sustainable Practices
A New Alliance for Sustainability in Finance: California and Switzerland Team Up to Tackle a Key Factor in Implementing Sustainable Practices
A New Alliance for Sustainability in Finance: California and Switzerland Team Up to Tackle a Key Factor in Implementing Sustainable Practices While sustainable policies at many levels have started to

Physics - Innovation / Technology - 29.10.2018
Quantum Technologies Flagship: Basel physicists participate in three research consortia
Quantum Technologies Flagship: Basel physicists participate in three research consortia
Today, the European Commission launched its flagship initiative on quantum technologies. Three research groups from the Department of Physics at the University of Basel are involved. The aim of the 1 billion euro research and technology funding program is to develop radically new and powerful quantum technologies by exploiting various quantum effects.

Pharmacology - Health - 27.10.2018
Two-year data for Novartis brolucizumab reaffirm superiority versus aflibercept in reducing retinal fluid in patients with nAMD
Year two results consistent with previously announced key secondary endpoint data on retinal fluid (IRF and/or SRF) showing superior reductions versus aflibercept   Superior reductions in central sub

Environment - Innovation / Technology - 26.10.2018

Life Sciences - Health - 26.10.2018
Subsides d’encouragement de projets de recherche FNS: 26 projets UNIL-CHUV acceptés - News
Subsides d'encouragement de projets de recherche FNS: 26 projets UNIL-CHUV acceptés Lors de la dernière session de printemps 2018, 26 projets de recherche UNIL-CHUV ont été financés par le FNS.

Earth Sciences - Law / Forensics - 26.10.2018

Innovation / Technology - Astronomy / Space Science - 25.10.2018
ESA ministerial Council sets the stage for the future
Bern, 25.10.2018 - The State Secretary for Education, Research and Innovation Mauro Dell'Ambrogio participated in the ESA's Intermediate Ministerial Meeting in Madrid today.

Health - Life Sciences - 24.10.2018

Health - Pharmacology - 24.10.2018
Roche announces FDA approval of Xofluza (baloxavir marboxil) for influenza
Roche announces FDA approval of Xofluza (baloxavir marboxil) for influenza First and only single-dose oral medicine approved to treat the flu Xofluza significantly reduced the duration of flu symptom

Careers / Employment - 24.10.2018

Health - Business / Economics - 23.10.2018
National Launch of Jazia Prime Vendor System in Tanzania
National Launch of Jazia Prime Vendor System in Tanzania
To supplement medicines and supplies that are out of stock at the Medical Stores Department (MSD) in Tanzania, Swiss TPH developed the Jazia Prime Vendor System (Jazia PVS).

Environment - History / Archeology - 23.10.2018
6,4 Million Euros for research into the birth of agriculture in Europe
6,4 Million Euros for research into the birth of agriculture in Europe
Media releases, information for representatives of the media Media Relations (E) An interdisciplinary team from the universities of Bern, Oxford and Thessaloniki was awarded a grant of 6.4 million euros from the European Research Council (ERC).

Music - 23.10.2018
Research into new audio experience resonates at Tinguely Museum in Basel
Research into new audio experience resonates at Tinguely Museum in Basel
Research into new audio experience resonates at Tinguely Museum in Basel A project funded by the SNSF is investigating the audio phenomena and sound culture associated with radio.

Health - Innovation / Technology - 23.10.2018
Alcon to develop SMART Suite digital health platform for cataract surgery
SMART Suite by Alcon will drive innovation in ophthalmology delivering personalized and seamless end-to-end care for cataract patients   As an open, secure cloud-enabled ecosystem, SMART Suite by Alc

Computer Science / Telecom - 23.10.2018
A new material for the strengthening of buildings
A new material for the strengthening of buildings
A new building material developed at Empa is about to be launched on the market: "memory-steel" can not only be used to reinforce new, but also existing concrete structures.

Life Sciences - Health - 23.10.2018
The epigenetics of cartilage repair and regeneration
The European Research Council (ERC) has awarded a prestigious ERC Synergy Grant - perhaps the most competitive funding scheme from ERC - to the research groups of Prof. Filippo Rijli from the

Health - Pharmacology - 23.10.2018
Novartis announces Lancet publication of pioneering study in migraine prevention showing efficacy of Aimovig where other treatments have failed
The LIBERTY trial is the first study of a CGRP-targeted therapy in a patient population where multiple preventive treatments had previously failed   Patients treated with Aimovig, reported significan

Pharmacology - Health - 22.10.2018
Roche’s Tecentriq plus chemotherapy (carboplatin and Abraxane) as an initial treatment helped people with advanced non-squamous non-small cell lung cancer live significantly longer compared to chemotherapy alone
Roche's Tecentriq plus chemotherapy (carboplatin and Abraxane) as an initial treatment helped people with advanced non-squamous non-small cell lung cancer live significantly longer compared to chemot

Pharmacology - Health - 22.10.2018
Novartis COMBI-AD study of Tafinlar + Mekinist continues to demonstrate relapse free survival benefit in patients with BRAF V600-mutant stage III melanoma
Extended follow up results confirm leading BRAF/MEK inhibitor combination Tafinlar + Mekinist continues to show relapse free survival benefit   Cure rate modeling which estimates fraction of patients

Health - Pharmacology - 21.10.2018
Roche’s investigational personalised medicine entrectinib shrank tumours in people with NTRK fusion-positive solid tumours
Entrectinib showed response irrespective of tumour type or spread to the central nervous system (CNS) Data will be submitted to global regulatory authorities, including the US Food and Drug Administr

Health - Pharmacology - 20.10.2018
Roche’s Tecentriq in combination with Abraxane improves outcomes as an initial treatment for people with PD-L1-positive metastatic triple-negative breast cancer
Tecentriq combination first immunotherapy regimen to demonstrate positive Phase III results in breast cancer Tecentriq and nab -paclitaxel significantly reduced the risk of disease worsening or death in both the intention-to-treat and PD-L1-positive populations Clinically meaningful overall survival improvement in the PD-L1-positive population at this interim analysis Data are being presented at the European Society for Medical Oncology (ESMO) 2

Health - Life Sciences - 19.10.2018
Novartis phase II GEOMETRY mono-1 trial of investigational medicine capmatinib (INC280) shows positive results in patients with MET mutated advanced NSCLC
Novartis phase II GEOMETRY mono-1 trial of investigational medicine capmatinib (INC280) shows positive results in patients with MET mutated advanced NSCLC Phase II study efficacy data showed overall response rate of 72.0% and 39.1%, respectively, in treatment-naive and previously treated patients with advanced MET exon-14 skipping mutated non-small cell lung cancer (NSCLC)   Clinical findings from ongoing study indicate safety prof

Health - 19.10.2018
Novartis announces presentation of new Lutathera NETTER-1 data
Novartis announces presentation of new Lutathera NETTER-1 data at ESMO demonstrating significant improvement in PFS regardless of baseline liver tumor burden Lutathera treatment was associated with a

Architecture - 19.10.2018
"Mediocre tools lead to mediocre thinking"
Architect Bernard Tschumi has donated the archives of his Bridge City project - developed for the City of Lausanne in 1988 - to EPFL.

Astronomy / Space Science - 18.10.2018

Health - Business / Economics - 18.10.2018

Health - 18.10.2018
One Health: Working together for human and animal health
Bern, 18.10.2018 - Prevention and early detection are central to effective control of communicable diseases and their vectors, such as mosquitoes.

Innovation / Technology - Computer Science / Telecom - 17.10.2018
Modifying a virtual environment in just a few clicks
Creating and modifying a virtual reality environment just got a lot easier thanks to software being released today by Imverse, an EPFL spin-off.

Event - Art and Design - 17.10.2018

Health - Life Sciences - 16.10.2018
Novartis 5-year data in psoriatic arthritis and ankylosing spondylitis reinforces Cosentyx leadership in spondyloarthritis
Data from the MEASURE 1 and FUTURE 1 studies show rapid and long-lasting sustained improvement in the signs and symptoms of ankylosing spondylitis (AS) and psoriatic arthritis (PsA) ,   In rheumatolo

Health - Pharmacology - 15.10.2018
Roche’s Kadcyla reduced the risk of disease recurring in people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment
Phase III KATHERINE study shows Kadcyla significantly improved invasive disease-free survival compared to Herceptin in people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment Data will be submitted to health authorities around the world, including the US Food and Drug Administration and European Medicines Agency Results will be presented at the 2018 San Antonio Breast Cancer Symposium in December Roche tod

Computer Science / Telecom - Law / Forensics - 11.10.2018
Joint research on Laser Deposition Welding
Joint research on Laser Deposition Welding
Empa and BeAM, a manufacturer of machines for metal 3D printing, are glad to announce an extensive research and development agreement.

Environment - 11.10.2018
Scientists head to Antarctica to study snow and icecaps
Scientists head to Antarctica to study snow and icecaps
EPFL scientists will soon be heading off to Antarctica, where they will spend four months collecting reams of meteorological data at Australia's Davis research station.